Related Experiment Video

Updated: Aug 15, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

[Hepatitis B in Poland in 2003]

Krzysztof Kuszewski1

  • 1Zakład Epidemiologii, Państwowego Zakładu Higieny, ul. Chocimska 24, 00-791 Warszawa. kkuszewski@pzh.gov.pl

Przeglad Epidemiologiczny
|September 30, 2005
PubMed

Insights

Hepatitis B cases in Poland decreased in 2003, with incidence falling to 4.7 per 100,000. This ongoing trend shows the effectiveness of control programs, bringing Poland

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health Epidemiology

Context:

  • In 2003, Poland registered 1,812 cases of hepatitis B.
  • Hepatitis B virus (HBV) and hepatitis C virus (HCV) mixed infections accounted for 6.5% of cases.
  • The incidence rate was 4.7 per 100,000 population.

Purpose:

  • To report the epidemiological data for hepatitis B in Poland for the year 2003.
  • To analyze trends in hepatitis B incidence in relation to control programs.
  • To compare Poland's hepatitis B incidence with European levels.

Summary:

  • A decrease of 209 cases and 0.6 per 100,000 in incidence was observed compared to the previous year.
  • The decreasing trend of hepatitis B incidence has been consistent in recent years.
  • Implementation of a hepatitis B control program has led to incidence rates below 5.0 per 100,000, aligning with European standards.

Impact:

  • Demonstrates the successful impact of public health interventions on reducing hepatitis B prevalence.
  • Highlights the importance of ongoing surveillance and control programs for viral hepatitis.
  • Provides valuable data for future public health strategies targeting hepatitis B elimination.

More Related Videos

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...